API Holdings (Pharmeasy) Unlisted Shares
Ranjan Pai’s MEMG and 360 One get CCI nod to invest in API Holdings
Entrackr
2 min read
API Holdings Ltd. Secures Strategic Investments Amidst PharmEasy's Challenges.
Expert Analysis:
Strategic CCI Approval: API Holdings Ltd. secures CCI approval for CCPS B subscription by MEMG and 360 One, reinforcing strategic investment direction.
Significant Financial Commitment: Undisclosed investment sizes, with MEMG's speculated Rs 1,000 crore investment for an 18% stake, indicate substantial financial commitment.
Synergistic Leadership Collaboration: Ranjan Pai's board presence underscores synergistic leadership collaboration, aligning strategic interests for API Holdings Ltd.
Short-term Hurdles: PharmEasy seeks Rs 3,500 crore to repay Goldman Sachs debt. Defaulted terms led to 50% valuation drop by Janus Henderson. Neuberger Berman slashed its valuation by 21.4% to $4.4 billion from a peak of $5.6 billion.
Improved Fiscal Performance: PharmEasy's revenue rose by 16% to Rs 6,644 crore in FY23. Cost-cutting measures reduced losses by 16% to Rs 2,289 crore by March 2023, per TheKredible.
Strategic Partnership:
Partnership with MEMG and 360 One signals strategic alignment, laying the foundation for sustained growth and market consolidation.
Long-term Optimism:
Even though PharmEasy faces some immediate difficulties, improvements in its operations give hope that it will be successful and become a dominant player in the market over the long term.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved